Reporting of adverse events (August 5, 2005).
Most Institutional Review Boards (IRBs) have difficulty coping with the volume of adverse events that study sponsors report to them. The FDA held a public meeting about this issue recently, and some written responses are available as PDF files at the following location:
This webpage was written by Steve Simon and was last modified on 07/08/2008. Category: Adverse events in clinical trials